(Source: Ministry of Health of New Zealand) The safety of human papilloma virus (HPV) vaccine has been extensively studied around the globe and has been subject to review by a number of international bodies. The vaccine was shown to have a good safety profile during large clinical trials involving more than 20,000 people from 30 countries, including New Zealand. Gardasil® has been approved for use in more than 125 countries, including New Zealand, Australia, the United States, Canada and countries in the European Union. In New Zealand, as in other countries, there is ongoing monitoring of vaccine safety. All applications seeking consent to distribute a medicine in New Zealand are evaluated...
↧